Tech Center 1600 • Art Units: 1621
This examiner grants 67% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17773414 | MrgprX2 Antagonists and Uses Thereof | Final Rejection | Dermira, Inc. |
| 17642292 | GLUE DEGRADERS AND METHODS OF USE THEREOF | Final Rejection | NOVARTIS AG |
| 17906089 | A COMBINATION THERAPY WITH NIROGACESTAT AND A BCMA-DIRECTED THERAPY AND USES THEREOF | Final Rejection | SpringWorks Therapeutics Inc. |
| 17801709 | POTENT AND SELECTIVE DEGRADERS OF ALK | Final Rejection | DANA-FARBER CANCER INSTITUTE, INC. |
| 18041058 | COMPANION DIAGNOSTIC FOR AXITINIB | Non-Final OA | The Regents of The University of Michigan |
| 17416876 | QUINOLINYL-PYRAZINE-CARBOXAMIDE COMPOUNDS AND USES THEREOF | Final Rejection | The Regents of the University of Michigan |
| 17760472 | NOVEL IMIDAZOLE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND USE THEREOF | Final Rejection | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS |
| 17423289 | COMPOSITIONS AND METHODS FOR IMMUNE MODULATION AND TREATMENT OF CANCER | Non-Final OA | Board of Trustees of Michigan State University |
| 17802872 | COMPOUNDS THAT MODULATE ANTI-TUMOR IMMUNITY AND METHODS OF DOING THE SAME | Non-Final OA | University of Florida Research Foundation, Incorporated |
| 18017078 | S100 PROTEINS AS NOVEL THERAPEUTIC TARGETS IN MYELOPROLIFERATIVE NEOPLASMS | Non-Final OA | ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM |
| 18017422 | SALT OF DIHYDROPYRIDO[2,3-D]PYRIMIDINONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | Non-Final OA | NANJING CHIA TAI TIANQING PHARMACEUTICAL CO., LTD. |
| 18002578 | Salts of Compound and Pharmaceutical Compositions Containing the Same | Final Rejection | Shenzhen Forward Pharmaceuticals Co., Limited. |
| 18127160 | BENZAMIDE COMPOUND AND USE THEREOF | Non-Final OA | WUHAN HUMANWELL INNOVATIVE DRUG RESEARCH AND DEVELOPMENT CENTER LIMITED COMPANY |
| 18270028 | 2-PYRIDONE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL APPLICATION THEREOF | Non-Final OA | SHANGHAI KUNHENG PHARMA-TECH CO., LTD |
| 17921257 | METHODS FOR SYNTHESIZING N-(PHENYLSULFONYL)BENZAMIDE COMPOUNDS AND INTERMEDIATES THEREOF | Non-Final OA | ASCENTAGE PHARMA GROUP CORP LIMITED |
| 17781699 | COMBINATION OF IAP INHIBITORS AND PARP OR MEK INHIBITORS OR OTHER CHEMOTHERAPEUTIC AGENTS | Non-Final OA | Ascentage Pharma Group Corp Limited |
| 17779893 | AHR INHIBITORS AND USES THEREOF | Non-Final OA | PAHR THERAPEUTICS, INC. |
| 17441484 | ORALLY ACTIVE SMALL MOLECULE INHIBITOR OF PAI-1 | Final Rejection | Renascience, Inc. |
| 18249209 | DOSING REGIMENS FOR CYCLIN-DEPENDENT KINASE 7 (CDK7) INHIBITORS | Non-Final OA | MEDIC Life Sciences Inc. |
| 18028651 | PHARMACEUTICAL COMPOSITIONS OF AMORPHOUS SOLID DISPERSIONS AND METHODS OF PREPARATION THEREOF | Non-Final OA | Shenzhen Pharmacin Co., Ltd. |
| 18042570 | QUINOLONE COMPOUNDS AND PROCESS FOR PREPARATION THEREOF | Non-Final OA | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN |
| 18002928 | NOVEL HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES | Non-Final OA | Elanco Animal Health GmbH |
| 17915817 | COMPOUND, PREPARATION METHOD THEREOF, AND USE THEREOF IN PREPARATION OF ANTI-CANCER DRUG | Non-Final OA | TIANJIN JIKUN MEDICAL TECHNOLOGY CO., LTD. |
| 17932200 | SELECTIVE P2X3 MODULATORS | Final Rejection | GlaxoSmithKline Intellectual Property (No.3) Limited |
| 17904677 | USE OF CASTALAGIN OR ANALOGS THEREOF FOR ANTI-CANCER EFFICACY AND TO INCREASE THE RESPONSE TO IMMUNE CHECKPOINT INHIBITORS | Non-Final OA | VAL-CHUM, LIMITED PARTNERSHIP |
| 17800029 | COMPOUND FOR TREATING GOUT, PREPARATION METHOD THEREFOR, AND USE THEREOF | Final Rejection | Huazhong Pharmaceutical Co., Ltd. |
| 17771945 | IMPROVED METHODS, KITS, COMPOSITIONS AND DOSING REGIMENS FOR THE USE OF HETEROCYCLIC INHIBITORS OF ERK1 AND ERK2 | Final Rejection | Asana Biosciences, LLC |
| 17770264 | COMPOUNDS AND METHODS FOR THE TREATMENT OF CRYPTOSPORIDIOSIS | Final Rejection | The University of Vermont and State Agriculture College |
| 17633617 | TrkB POSITIVE ALLOSTERIC MODULATORS | Final Rejection | Université Grenoble Alpes |
| 17632437 | Chewing Gum Compositions Containing Cannabinoids | Non-Final OA | ADVANCED FEMALE TECHNOLOGIES LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy